Toutes les actualités
Our articles

An evaluation result, indicator of excellence

In July 2024, the IMS was given the highest score being an A by the Interdisciplinary Thematic Institutes during its mid-term evaluation. What are the ITI (Interdisciplinary thematic institutes) ? The ITI are the pilar of the research and training evolution of the University of Strasbourg. Lead by an international jury, the midterm evaluation is renewing the 13...

Seminar at Okayama University

Dominique bagnard invited as speaker On Thursday, 19 September, Dominique Bagnard will be in Tokyo to give a summary of the "Biotechnologies - Organoids on a chip - Openings to improved drug testing and to reduction of animal sacrifice". The talk will briefly introduce organoids, with focus on what they are and how they can be fabricated.This seminar is open to all,...

Library IMS: the new pharmaceutical revolution

What if you could find all the resources you need to make your research project a real success? It's now possible with the IMS Library, with 578 different compounds in stock and ready to be targeted! What exactly is the IMS library? A collection of chemical compounds designed for use in pharmaceutical research, the IMS library has become an indispensable tool in the...

Biodol Therapeutics raises €7 million to bring its next-generation pain therapy to the clinic!

Biodol Therapeutics, an innovative French start-up founded by Didier Rognan, Research Director at the CNRS, Director of the Laboratoire d'Innovation Thérapeutique and member of Strasbourg's Institut du Médicament, has successfully raised €7 million to advance its next-generation pain therapy into clinical trials.Specializing in the development of cutting-edge pain relief treatments,...

IMS Day – a look back at the event

Welcomed at 9am by a coffee reception in the Bâtiment de la Présidence at the Université de Strasbourg, over 100 people attended the IMS Day on May 6, 2024.This event, hosted by renowned speakers and companies in the field of scientific innovation such as Serendip Innovations and Domain Therapeutics, was an opportunity to bring together researchers, teachers and students, all...

Our teams meet HealthTech companies !

On the morning of Monday March 11, 2024, the 12 research laboratories of the Institut du Médicament de Strasbourg (IMS) met with 15 healthtech companies at the API pole in Ilkirch.An opportunity for those present to discuss potential collaborative projects.Here's a look back at the event! A good start to the day with breakfast 🥐 The API pole opened...